Cardiac resynchronization therapy guided by cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 12, Issue 1, 2010, Pages

  Leyva, Francisco ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; HEART FAILURE; HEART LEFT VENTRICLE; HUMAN; PATIENT ASSESSMENT; PRIORITY JOURNAL; QRS COMPLEX; RISK REDUCTION; TREATMENT RESPONSE;

EID: 79953808308     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-12-64     Document Type: Article

References (130)

1. Four chamber pacing in dilated cardiomyopathy. Cazeau S, Ritter P, Bachdach S, Lazarus A, Limousin M, Henao L, Mundler O, Daubert JC, Mugica J, Pacing Clin Electrophysiol 1994 17 11 Pt 2 1974 1979 10.1111/j.1540-8159.1994. tb03783.x 7845801 (Pubitemid 24362932)
2. Acute hemodynamic effects of biventricular DDD pacing in patients with end stage heart failure. Leclercq C, Cazeau S, Le Breton H, Ritter P, Mabo P, Gras D, Pavin D, Lazarus A, Daubert JC, J Am Coll Cardiol 1998 32 7 1825 1831 10.1016/S0735-1097(98)00492-6 9857858 (Pubitemid 29010441)
3. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, Klein H, Karmer A, Ding J, Salo R, et al. Circulation 1999 99 2993 3001 10368116 (Pubitemid 29270428)
4. Effects of multisite biventricular pacing in patients with heart failure and interventricular conduction delay. Cazeau S, Leclercq C, Lavergene T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, et al. N Engl J Med 2001 344 873 880 10.1056/NEJM200103223441202 11259720 (Pubitemid 32224395)
5. for the Cardiac Resynchronization-Heart Failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, N Eng J Med 2005 352 1539 1549 10.1056/NEJMoa050496 (Pubitemid 40517094)
6. for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced heart failure. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass D, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, et al. N Eng J Med 2004 350 2140 2150 10.1056/NEJMoa032423 (Pubitemid 38637994)
7. Cardiac-resynchronization therapy for the prevention of heart-failure events. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, Foster E, Greenberg H, Higgins SL, et al. N Engl J Med 2009 361 14 1329 1338 10.1056/NEJMoa0906431 19723701
8. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Torok T, Linde C, J Am Coll Cardiol 2009 54 20 1837 1846 10.1016/j.jacc.2009.08.011 19800193
9. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study. Funck RC, Blanc JJ, Mueller HH, Schade-Brittinger C, Bailleul C, Maisch B, Europace 2006 8 8 629 635 10.1093/europace/eul075 16864616 (Pubitemid 44295761)
10. Cardiac resynchronization therapy in patients with a narrow QRS. Holzmeister J, Hurlimann D, Steffel J, Ruschitzka F, Current heart failure reports 2009 6 1 49 56 10.1007/s11897-009-0009-5 19265593
11. What is treatment success in cardiac resynchronization therapy? Foley PW, Leyva F, Frenneaux MP, Europace 2009 11 Suppl 5 2258 65 10.1093/europace/eup308 19861392
12. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987 316 23 1429 1435 10.1056/NEJM198706043162301 2883575
13. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation 1994 90 4 1765 1773 7923660
14. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Pitt B, Zannad F, Remme WJ, for the Randomized Aldactone Evaluation Study Investigators, et al. N Engl J Med 1999 341 709 717 10.1056/NEJM199909023411001 10471456 (Pubitemid 29407370)
15. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Prinzen FW, Augustijn CH, Arts T, Allessie MA, Reneman RS, Am J Physiol 1990 259 300 H308 2386214
16. Effect of alteration of left ventricular activation sequence on the left ventricular end-systolic pressure-volume relation in closed-chest dogs. Park RC, Little WC, O'Rourke RA, Circ Res 1985 57 5 706 717 4053304 (Pubitemid 16200680)
17. Influence of pacing site on canine left ventricular contraction. Burkhoff D, Oikawa RY, Sagawa K, Am J Physiol 1986 251 428 H435 3740295
18. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. Pitzalis MV, Iacoviello M, Romito R, Guida P, De Tomasi E, Luzzi G, Anaclerio M, Forleo C, Rizzon P, J Am Col Cardiol 2002 40 1615 1622 10.1016/S0735-1097(02)02337-9 (Pubitemid 35253639)
19. Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodelling response after cardiac resynchronisation therapy. Yu CM, Zhang Q, Chan YS, Chan CK, Yip GW, Kum LC, Wu EB, Lee PW, Lam YY, Chan S, et al. Heart 2006 92 10 1452 1456 10.1136/hrt.2005.083592 16621873 (Pubitemid 44578840)
20. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP, Am J Cardiol 2003 91 6 684 688 10.1016/S0002-9149(02)03404-5 12633798 (Pubitemid 36287458)
21. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, Van der Wall EE, Schalij MJ, J Am Col Cardiol 2004 44 1834 1840 10.1016/j.jacc.2004.08.016 (Pubitemid 39424084)
22. Results of the Predictors of Response to CRT (PROSPECT) Trial. Chung E, Leon A, Tavazzi L, Sun J, Nihoyannopoulos P, Merlino J, Abraham W, Guio S, Leclerq C, Bax J, et al. Circulation 2008 117 20 2608 2616 10.1161/ CIRCULATIONAHA.107.743120 18458170
23. Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony. Hawkins NM, Petrie MC, Burgess MI, McMurray JJ, J Am Coll Cardiol 2009 53 21 1944 1959 10.1016/j.jacc.2008.11.062 19460607
24. Hype and hope in the use of echocardiography for selection for cardiac resynchronization therapy: the tower of Babel revisited. Marwick T, Circulation 2008 117 2573 2576 10.1161/CIRCULATIONAHA.108.772475 18490533
25. Echocardiographic parameters of mechanical synchrony in healthy individuals. Conca C, Faletra FF, Miyazaki C, Oh J, Mantovani A, Klersy C, Sorgente A, Pedrazzini GB, Pasotti E, Moccetti T, et al. Am J Cardiol 2009 103 1 136 142 10.1016/j.amjcard.2008.08.039 19101244
26. Agreement Is Poor Among Current Criteria Used to Define Response to Cardiac Resynchronization Therapy. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, Leon AR, Oshinski JN, Circulation 2010 121 18 1985 1991 10.1161/CIRCULATIONAHA.109.910778 20421518
27. An epidemic of dyssynchrony. Kass D, J Am Coll Cardiol 2008 51 12 17 10.1016/j.jacc.2007.09.027 18174030
28. Mechanical dyssynchrony in congestive heart failure. Nagueh S, J Am Coll Cardiol 2008 51 18 22 10.1016/j.jacc.2007.08.052 18174031
29. Regional left ventricle mechanical asynchrony in patients with heart disease and normal QRS duration: implication for biventricular pacing therapy. Yu CM, Yang H, Lau CP, Wang Q, Wang S, Lam L, Sanderson JE, Pacing Clin Electrophysiol 2003 26 2 Pt 1 562 570 10.1046/j.1460-9592.2003.00095.x 12710315 (Pubitemid 36403335)
30. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Yu CM, Lin H, Zhang Q, Sanderson JE, Heart 2003 89 54 60 10.1136/heart.89.1.54 12482792 (Pubitemid 36044290)
31. Prevalence of mechanical dyssynchrony in heart failure patients with different QRS durations. Haghjoo M, Bagherzadeh A, Fazelifar A, Haghighi Z, Esmaielzadeh M, Alizadeh A, Emkanjoo Z, Sadeghpour A, Samiei N, Farahani M, et al. Pacing Clin Electrophysiol 2007 30 616 622 10.1111/j.1540-8159.2007.00722.x 17461871 (Pubitemid 46656107)
32. Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex. Takemoto Y, Hozumi T, Sugioka K, Takagi Y, Matsumura Y, Yoshiyama M, Abraham T, Yoshikawa J, J Am Coll Cardiol 2007 49 778 783 10.1016/j.jacc.2006.05.081 17306707 (Pubitemid 46242184)
33. Assessment of cardiac asynchrony by radionuclide phase analysis: correlation with ventricular function in patients with narrow or prolonged QRS interval. Marcassa C, Campini R, Verna E, Ceriani L, Giannuzzi P, Eur J Heart Fail 2007 9 484 490 10.1016/j.ejheart.2007.01.002 17347038 (Pubitemid 46561491)
34. Intraventricular Dyssynchrony Predicts Mortality and Morbidity Following Cardiac Resynchronization Therapy: A Study Using Cardiovascular Magnetic Resonance Tissue Synchronization Imaging. Chalil S, Stegemann B, Muhyaldeen S, Khadjooi K, Smith R, Jordan P, Leyva F, J Am Coll Cardiol 2007 50 243 252 10.1016/j.jacc.2007.03.035 17631217 (Pubitemid 47033969)
35. Electrical and mechanical components of dyssynchrony in heart failure patients with normal QRS duration and left bundle-branch block: impact of left and biventricular pacing. Turner M, Bleasdale R, Vinereanu D, Mumford C, Paul V, Fraser A, Frenneaux M, Circulation 2004 109 2544 2549 10.1161/01.CIR. 0000131184.40893.40 15148267 (Pubitemid 38720554)
36. Systolic and diastolic dyssynchrony in patents with diastolic heart failure and the effect of medical therapy. Wang J, Kurrelmeyer K, Torre-Amione G, Nagueh S, J Am Coll Cardiol 2007 49 88 96 10.1016/j.jacc.2006.10.023 17207727 (Pubitemid 46026901)
37. Relation of left ventricular systolic dyssynchrony in patients with heart failure to left ventricular ejection fraction and to QRS duration. Chan CP, Zhang Q, Yip GW, Fung JW, Lam YY, Lee PW, Wu EB, Shang Q, Liang Y, Yu CM, Am J Cardiol 2008 102 5 602 605 10.1016/j.amjcard.2008.04.032 18721520
38. Radial dyssynchrony assessed by cardiovascular magnetic resonance in relation to left ventricular function, myocardial scarring and QRS duration in patients with heart failure. Foley PW, Khadjooi K, Ward JA, Smith RE, Stegemann B, Frenneaux MP, Leyva F, J Cardiovasc Magn Reson 2009 11 1 50 56 10.1186/1532-429X-11-50 19930713
39. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, De Spirito S, Guerra R, Patruno N, Serra F, J Am Coll Cardiol 2003 42 2117 2124 10.1016/j.jacc.2003.08.024 14680737 (Pubitemid 37549895)
40. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. Yu CM, Chan Y, Zhang Q, Yip G, Chan C, Kum L, Wu L, Lee A, Lam Y, Fung J, J Am Coll Cardiol 2006 48 2251 2257 10.1016/j.jacc.2006.07.054 17161255 (Pubitemid 44873057)
41. Beneficial effects of biventricular pacing in patients with a "narrow" QRS. Gasparini M, Mantica M, Galimberti P, Marconi M, Genovese L, Faletra F, Simonini S, Klersy C, Coates R, Gronda E, Pacing Clin Electrophysiol 2003 26 1 Pt 2 169 174 10.1046/j.1460-9592.2003.00010.x 12687806 (Pubitemid 36399133)
42. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. Beshai J, Grimm R, Nagueh S, Baker J, Beau S, Greenberg S, Pires L, Tchou P, for the RethinQ Study Investigators, N Eng J Med 2007 357 2461 2471 10.1056/NEJMoa0706695 (Pubitemid 350272785)
43. Inclusion and exclusion criteria for CRT. Auricchio A, Leyva F, Heart Rhythm 2009 6 8 1235 1237 10.1016/j.hrthm.2009.03.053 19632640
44. Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance. Barnett D, Phillips S, Longson C, Heart 2007 93 1134 1135 10.1136/hrt.2007.127563 17699177 (Pubitemid 47310998)
45. Feasibility and initial experience of assessment of mechanical dyssynchrony using cardiovascular magnetic resonance and semi-automatic border detection. Koos R, Neizel M, Schummers G, Krombach GA, Stanzel S, Gunther RW, Kelm M, Kuhl HP, J Cardiovasc Magn Reson 2008 10 1 49 10.1186/1532-429X-10-49 18983646
46. Quantification of left ventricular internal flow from cardiac magnetic resonance images in patients with dyssynchronous heart failure. Fornwalt BK, Gonzales PC, Delfino JG, Eisner R, Leon AR, Oshinski JN, J Magn Reson Imaging 2008 28 2 375 381 10.1002/jmri.21446 18666147
47. MR imaging of motion with spatial modulation of magnetization. Axel L, Dougherty L, Radiology 1989 171 3 841 845 2717762 (Pubitemid 19134952)
48. Myocardial tissue tagging with cardiovascular magnetic resonance. Shehata ML, Cheng S, Osman NF, Bluemke DA, Lima JA, J Cardiovasc Magn Reson 2009 11 1 55 10.1186/1532-429X-11-55 20025732
49. Quantitative ischemia detection during cardiac magnetic resonance stress testing by use of FastHARP. Kraitchman DL, Sampath S, Castillo E, Derbyshire JA, Boston RC, Bluemke DA, Gerber BL, Prince JL, Osman NF, Circulation 2003 107 15 2025 2030 10.1161/01.CIR.0000062684.47526.47 12668517 (Pubitemid 36506078)
50. Predictors of systolic augmentation from left ventricular pre excitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Nelson GS, Curry CW, Wyman BT, Kramer A, Declerck J, Talbot M, Douglas MR, Berger RD, McVeigh ER, Kass DA, Circulation 2000 101 23 2703 2709 10851207 (Pubitemid 30390573)
51. Effects of single-and biventricular pacing on temporal and spatial dynamics of ventricular contraction. Wyman BT, Hunter WC, Prinzen FW, Faris OP, McVeigh ER, Am J Physiol Heart Circ Physiol 2002 282 372 H379 11748084
52. Cardiac dyssynchrony analysis using circumferential versus longitudinal strain: Implications for assessing cardiac resynchronization. Helm RH, Lecquercq C, Faris Q, Ozturk C, McVeigh E, Lardo AC, Kass D, Circulation 2005 111 2760 2767 10.1161/CIRCULATIONAHA.104.508457 15911694 (Pubitemid 40791547)
53. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle branch block. Leclercq C, Fairs O, Tunin R, Johnson J, Kato R, Evans F, Spinelli J, Halperin H, McVeigh E, Kass DA, Circulation 2002 106 1760 1763 10.1161/01.CIR.0000035037. 11968.5C 12356626
54. Three-dimensional mapping of optimal left ventricular pacing site for cardiac resynchronization. Helm RH, Byrne M, Helm PA, Daya SK, Osman NF, Tunin R, Halperin HR, Berger RD, Kass DA, Lardo AC, Circulation 2007 115 8 953 961 10.1161/CIRCULATIONAHA.106.643718 17296857 (Pubitemid 46328288)
55. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. Bilchick KC, Dimaano V, Wu KC, Helm RH, Weiss RG, Lima JA, Berger RD, Tomaselli GF, Bluemke DA, Halperin HR, et al. Jacc 2008 1 5 561 568 19356481
56. Twist and untwist mechanics of the left ventricle. Sengupta PP, Khandheria BK, Narula J, Heart failure clinics 2008 4 3 315 324 10.1016/j.hfc.2008.03.001 18598983 (Pubitemid 351885513)
57. Deformation analysis of 3D tagged cardiac images using an optical flow method. Xu C, Pilla J, Isaac G, Gorman J, Blom A, Gorman R, Ling Z, Dougherty L, J Cardiovasc Magn Reson 2010 12 1 19 25 10.1186/1532-429X-12-19 20353600
58. Comparison of echocardiographic dyssynchrony assessment by tissue velocity and strain imaging in subjects with or without systolic dysfunction and with or without left bundle-branch block. Miyazaki C, Powell BD, Bruce CJ, Espinosa RE, Redfield MM, Miller FA, Hayes DL, Cha YM, Oh JK, Circulation 2008 117 20 2617 2625 10.1161/CIRCULATIONAHA.107.733675 18474810
59. Development and evaluation of tracking algorithms for cardiac wall motion analysis using phase velocity MR imaging. Constable RT, Rath KM, Sinusas AJ, Gore JC, Magn Reson Med 1994 32 1 33 42 10.1002/mrm.1910320106 8084235 (Pubitemid 24198553)
60. Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy. Marsan NA, Bleeker GB, van Bommel RJ, Ypenburg C, Delgado V, Borleffs CJ, Holman ER, van der Wall EE, Schalij MJ, Bax JJ, Am J Cardiol 2009 103 5 690 694 10.1016/j.amjcard.2008.11.008 19231335
61. Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy:head-to-head comparison between tissue Doppler imaging and velocity-encoded magnetic resonance imaging. Westenberg JJM, Lamb H, van der Geest RJ, Bleeker GA, Holman ER, Schalij MJ, de Roos A, Van der Wall EE, Reiber JHC, Bax JJ, J Am Coll Cardiol 2006 47 2042 2048 10.1016/j.jacc.2006.01.058 16697323
62. Imaging longitudinal cardiac strain on short-axis images using strain-encoded MRI. Osman NF, Sampath S, Atalar E, Prince JL, Magn Reson Med 2001 46 2 324 334 10.1002/mrm.1195 11477637 (Pubitemid 32703279)
63. Interventricular mechanical dyssynchrony: quantification with velocity-encoded MR imaging. Muellerleile K, Baholli L, Groth M, Barmeyer AA, Koopmann K, Ventura R, Koester R, Adam G, Willems S, Lund GK, Radiology 2009 253 2 364 371 10.1148/radiol.2532090145 19703849
64. Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy? Gasparini M, Mantica M, Galimberti P, Bocciolone M, Genovese L, Mangiavacchi M, Marchesina UL, Faletra F, Klersy C, Coates R, et al. Pacing Clin Electrophysiol 2003 26 1 Pt 2 162 168 10.1046/j.1460-9592.2003.00009.x 12687805 (Pubitemid 36399132)
65. Impact of coronary sinus lead position on biventricular pacing: mortality and echocardiographic evaluation during long-term follow-up. Rossillo A, Verma A, Saad EB, Corrado A, Gasparini G, Marrouche NF, Golshayan AR, McCurdy R, Bhargava M, Khaykin Y, et al. J Cardiovasc Electrophysiol 2004 15 10 1120 1125 10.1046/j.1540-8167.2004.04089.x 15485432 (Pubitemid 39426037)
66. Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy. Kronborg MB, Albertsen AE, Nielsen JC, Mortensen PT, Europace 2009 11 9 1177 1182 10.1093/europace/eup202 19661114
67. Doppler myocardial imaging in patients with heart failure receiving biventricular pacing treatment. Ansalone G, Giannantoni P, Ricci R, et al. Am Heart J 2001 142 881 896 10.1067/mhj.2001.117324 11685178 (Pubitemid 33016209)
68. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Murphy RT, Sigurdsson G, Mulamalla S, Agler D, Popovic ZB, Starling RC, Wilkoff BL, Thomas JD, Grimm RA, Am J Cardiol 2006 97 11 1615 1621 10.1016/j.amjcard.2005.12.054 16728225 (Pubitemid 43737035)
69. Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization. Becker M, Hoffmann R, Schmitz F, Hundemer A, Kuhl H, Schauerte P, Kelm M, Franke A, Am J Cardiol 2007 100 11 1671 1676 10.1016/j.amjcard.2007.07.019 18036367 (Pubitemid 350122330)
70. Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study. Becker M, Franke A, Breithardt OA, Ocklenburg C, Kaminski T, Kramann R, Knackstedt C, Stellbrink C, Hanrath P, Schauerte P, et al. Heart 2007 93 10 1197 1203 10.1136/hrt.2006.095612 17309913 (Pubitemid 47492902)
71. Myocardial Infarction Does Not Preclude Electrical and Hemodynamic Benefits of CRT in Dyssynchronous Canine Hearts. Rademakers L, VanKerckhoven R, vanDeursen C, Strik M, vanHunnik A, Kuiper M, Lampert A, Klersy C, Leyva F, Auricchio A, et al. Circ Arrhythm Electrophysiol 2010 20495014
72. Towards new understanding of the heart structure and function. Torrent-Guasp F, Kocica MJ, Corno AF, Komeda M, Carreras-Costa F, Flotats A, Cosin-Aguillar J, Wen H, Eur J Cardiothorac Surg 2005 27 191 201 10.1016/j.ejcts.2004.11.026 15691670 (Pubitemid 40193126)
73. Left ventricular fibre architecture in man. Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH, Br Heart J 1981 45 3 248 263 10.1136/hrt.45.3.248 7008815 (Pubitemid 11137851)
74. Effect of myocardial fibre architecture on the behaviour of the human left ventricle in diastole. Yettram A, Vinson CA, Gibson DG, J Biomed Eng 1983 5 321 328 10.1016/0141-5425(83)90008-0 6632844
75. Electrical heterogeneity within the ventricular wall. Antzelevitch C, Fish J, Basic Res Cardiol 2001 96 517 527 10.1007/s003950170002 11770069 (Pubitemid 33121024)
76. Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias. Cassidy D, Vassallo J, Miller J, Poll D, Buxton A, Marchinski F, Josephson M, Circulation 1986 73 645 652 3948367 (Pubitemid 16081422)
77. Concordance Between Mechanical and Electrical Dyssynchrony in Heart Failure Patients: A Function of the Underlying Cardiomyopathy? Tournoux F, Donal E, Leclercq C, De Place C, Crocq C, Solnon A, Cohen-Solal A, Mabo P, Daubert JC, J Cardiovasc Electrophysiol 2007 18 1022 1027 10.1111/j.1540-8167.2007. 00900.x 17666067 (Pubitemid 47416564)
78. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. Leclercq C, Gadler F, Kranig W, Ellery S, Gras D, Lazarus A, Clémenty J, Boulogne E, Daubert J, TRIP-HF (Triple Resynchronization In Paced Heart Failure Patients) Study Group, J Am Coll Cardiol 2008 51 1455 1462 10.1016/j.jacc.2007.11.074 18402900 (Pubitemid 351479229)
79. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE, J Am Coll Cardiol 2002 39 1151 1158 10.1016/S0735-1097(02)01726-6 11923039 (Pubitemid 34267418)
80. Visualisation of presence, location and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kin RJ, Lancet 2001 357 21 28 10.1016/S0140-6736(00)03567-4 11197356 (Pubitemid 32056497)
81. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM, N Engl J Med 2000 343 1445 1453 10.1056/NEJM200011163432003 11078769
82. Infarct viability influences ventricular remodelling after late recanalisation of an occluded infarct related artery. Bellenger NG, Yousef Z, Kajappan K, Marber MS, Pennell DJ, Heart 2005 91 478 483 10.1136/hrt.2004.034918 15772205 (Pubitemid 40432775)
83. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Meluzin J, Cerny J, Frelich M, Stetka F, Spiranova F, Popelova J, Stipal R, J Am Col Cardiol 1998 32 912 920 10.1016/S0735-1097(98)00324-6 (Pubitemid 28459578)
84. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SK, McIntyre WJ, Thomas JD, Circulation 1994 90 2687 2694 7994809
85. Gadolinium cardiovascular magnetic resonance predicts myocardial dysfunction and remodelling in patients with heart failure undergoing beta-blocker therapy. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker MA, Johnson M, Cotts WG, Klocke FJ, Bonow RO, Judd RM, et al. Circulation 2003 108 1945 1953 10.1161/01.CIR.0000095029.57483.60 14557364 (Pubitemid 37296539)
86. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. McCrohon JA, Moon JJC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJS, Pennell DJ, Circulation 2003 108 54 59 10.1161/01.CIR.0000078641.19365.4C 12821550 (Pubitemid 36859020)
87. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, Poole-Wilson PA, Pennell DJ, J Am Coll Cardiol 2006 48 10 1977 1985 10.1016/j.jacc.2006.07.049 17112987 (Pubitemid 44738448)
88. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. White JA, Yee R, Yuan X, Krahn A, Skanes A, Parker M, Klein G, Drangova M, J Am Coll Cardiol 2006 48 10 1953 1960 10.1016/j.jacc.2006.07.046 17112984 (Pubitemid 44738444)
89. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Chalil S, Foley P, Muyhaldeen S, Patel K, Yousef Z, Smith R, Frenneaux M, Leyva F, Europace 2007 9 1031 1037 10.1093/europace/eum133 17933857 (Pubitemid 351773274)
90. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Adelstein EC, Saba S, Am Heart J 2007 153 1 105 112 10.1016/j.ahj.2006.10.015 17174647 (Pubitemid 44880886)
91. Electrical impedance properties of normal and chronically infarcted ventricular myocardium. Schwartzman D, Chang I, Michele JJ, Moritznik MS, Foster KR, J Interv Card Electrophysiol 1999 3 213 224 10.1023/A:1009887306055 10490477
92. Combined Epicardial and Endocardial Electroanatomic Mapping in a Porcine Model of Healed Myocardial Infarction. Reddy VY, Wrobleski D, Houghtaling C, Josephson ME, Ruskin JN, Circulation 2003 107 25 3236 3242 10.1161/01.CIR. 0000074280.62478.E1 12796129 (Pubitemid 36793097)
93. Feasibility of adjusting paced left ventricular activation by manipulating stimulus strength. Tedrow U, Maisel W, Epstein L, Soejima K, Stevenson W, J Am Coll Cardiol 2004 44 2249 2251 10.1016/j.jacc.2004.09.008 15582325 (Pubitemid 39576047)
94. Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. Breithardt OA, Stellbrink C, Kramer AP, Sinha AM, Franke A, Salo R, Schiffgens B, Huvelle E, Auricchio A, PATH-CHF Study Group, J Am Coll Cardiol 2002 40 3 536 545 10.1016/S0735-1097(02)01987-3 12142123 (Pubitemid 34833172)
95. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Chalil S, Stegemann B, Muhyaldeen S, Khadjooi S, Foley P, Smith R, Leyva F, Pacing Clin Electrophysiol 2007 10 1201 1207 10.1111/j.1540-8159.2007.00841.x (Pubitemid 47493122)
96. Statistical reasoning in medicine. Moyé L, New York, NY: Springer 2006
97. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM, Circulation 1997 95 12 2660 2667 9193435 (Pubitemid 27255495)
98. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV, JAMA 2003 290 19 2581 2587 10.1001/jama.290.19.2581 14625335 (Pubitemid 37443288)
99. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Anker S, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos C, Cicoira M, Shamim W, Kemp M, et al. Circulation 2003 107 15 1991 1997 10.1161/01.CIR.0000065637. 10517.A0 12707250 (Pubitemid 36506072)
100. Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. Leyva F, Foley PW, Stegemann B, Ward JA, Ng LL, Frenneaux MP, Regoli F, Smith RE, Auricchio A, Heart 2009 95 19 1619 1625 10.1136/hrt.2009.173880 19592389
101. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW, J Am Coll Cardiol 2000 35 3 681 689 10.1016/S0735-1097(99)00608-7 10716471 (Pubitemid 30167025)
102. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Smilde TD, Hillege HL, Navis G, Boomsma F, de Zeeuw D, van Veldhuisen DJ, Am Heart J 2004 148 1 165 172 10.1016/j.ahj.2004.02.007 15215807 (Pubitemid 38900497)
103. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ, Circulation 2000 102 2 203 210 10889132 (Pubitemid 30451778)
104. The Seattle Heart Failure Model: prediction of survival in heart failure. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, et al. Circulation 2006 113 11 1424 1433 10.1161/CIRCULATIONAHA.105.584102 16534009 (Pubitemid 43739439)
105. Heart failure is not a diagnosis. Patel K, Leyva F, Frenneaux M, Int J Clin Pract 2008 62 526 528 10.1111/j.1742-1241.2008.01720.x 18324949 (Pubitemid 351348043)
106. The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Wikstrom G, Blomstrom-Lundqvist C, Andren B, Lonnerholm S, Blomstrom P, Freemantle N, Remp T, Cleland JG, Eur Heart J 2009 30 7 782 788 10.1093/eurheartj/ehn577 19168870
107. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Alpert JS, Thygesen K, Antman E, Bassand JP, J Am Coll Cardiol 2000 36 959 969 10.1016/S0735-1097(00)00804-4 10987628
108. Silent myocardial ischemia and infarction: insights from the Framingham Study. Kannel WB, Cardiology clinics 1986 4 4 583 591 3779719 (Pubitemid 17230678)
109. Myocardial infarction with normal coronary angiogram. Possible mechanism of smoking risk in coronary artery disease. McKenna WJ, Chew CY, Oakley CM, Br Heart J 1980 43 5 493 498 10.1136/hrt.43.5.493 7378207 (Pubitemid 10005454)
110. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH, Davies SW, Pennell DJ, Prasad SK, Eur Heart J 2007 28 10 1242 1249 10.1093/eurheartj/ehm113 17478458 (Pubitemid 47343853)
111. Differentiation of ischemic from nonischemic cardiomyopathy during dobutamine stress by left ventricular long-axis function: additional effect of left bundle-branch block. Duncan AM, Francis DP, Gibson DG, Henein MY, Circulation 2003 108 10 1214 1220 10.1161/01.CIR.0000087401.19332.B7 12939221 (Pubitemid 37099990)
112. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM, Circulation 1999 100 19 1992 2002 10556226 (Pubitemid 29529292)
113. Magnetic resonance imaging as a potential gold standard for infarct quantification. Carlsson M, Arheden H, Higgins CB, Saeed M, Journal of electrocardiology 2008 41 6 614 620 10.1016/j.jelectrocard.2008.06.010 18817927
114. The use of cardiac magnetic resonance imaging to determine the aetiology of left ventricular disease and cardiomyopathy. Germans T, van Rossum AC, Heart 2008 94 4 510 518 10.1136/hrt.2007.122770 18347381 (Pubitemid 351441415)
115. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ, J Cardiovasc Magn Reson 2008 10 42 10.1186/1532-429X-10-42 18817553
116. T2 quantification for improved detection of myocardial edema. Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV, Simonetti OP, J Cardiovasc Magn Reson 2009 11 56 10.1186/1532-429X-11-56 20042111
117. Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome. Raman SV, Simonetti OP, Winner MW, Dickerson JA, He X, Mazzaferri EL Jr, Ambrosio G, J Am Coll Cardiol 55 22 2480 2488
118. Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices: An American Heart Association Scientific Statement From the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: Endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, Martin ET, Smith JM, Wilke N, et al. Circulation 2007 116 24 2878 2891 10.1161/CIRCULATIONAHA.107.187256 18025533 (Pubitemid 350291228)
119. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Achenbach S, Moshage W, Diem B, Bieberle T, Schibgilla V, Bachmann K, Am Heart J 1997 134 3 467 473 10.1016/S0002-8703(97)70083-8 9327704 (Pubitemid 27431252)
120. Effect of 1.5 tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. Hayes DL, Holmes DR Jr, Gray JE, J Am Coll Cardiol 1987 10 4 782 786 10.1016/S0735-1097(87)80270-X 3655146 (Pubitemid 17163101)
121. Cardiac magnetic resonance with a pacemaker in-situ: can it be done? Pennell D, J Cardiovasc Magn Reson 1999 1 72
122. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K, J Am Coll Cardiol 2004 43 7 1315 1324 10.1016/j.jacc.2003.12.016 15063447 (Pubitemid 38452612)
123. Image-guided cardiac resynchronization. Schwartzman D, Schelbert E, Adelstein E, Gorcsan J, Soman P, Saba S, Europace 12 6 877 880 10.1093/europace/euq103 20400444
124. Visualization of the cardiac venous system using cardiac magnetic resonance. Chiribiri A, Kelle S, Gotze S, Kriatselis C, Thouet T, Tangcharoen T, Paetsch I, Schnackenburg B, Fleck E, Nagel E, Am J Cardiol 2008 101 3 407 412 10.1016/j.amjcard.2007.08.049 18237610 (Pubitemid 351192923)
125. Timing of cardiac contraction in humans mapped by high-temporal- resolution MRI tagging: early onset and late peak of shortening in lateral wall. Zwanenburg JJM, Gotte MJW, Kuijer JPA, Heethaar RM, van Rossum AC, Marcus JT, Am J Physiol Heart Circ Physiol 2004 286 5 1872 1880 10.1152/ajpheart.01047.2003 14726304 (Pubitemid 38525476)
126. 2010 Focused Update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ, et al. Eur Heart J
127. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, et al. J Am Coll Cardiol 2008 51 21 1 62 10.1016/j.jacc.2008.02.032 18498951 (Pubitemid 351689050)
128. Cardiac resynchronization therapy: Current state of the art: Cost versus benefit. Auricchio A, Abraham WT, Circulation 2004 109 3 300 307 10.1161/01.CIR.0000115583.20268.E1 14744954 (Pubitemid 38133893)
129. Magnetic Resonance Imaging Assessment of Ventricular Dyssynchrony: Current and Emerging Concepts. Lardo AC, Abraham TP, Kass DA, J Am Coll Cardiol 2005 46 12 2223 2228 10.1016/j.jacc.2005.09.015 16360050 (Pubitemid 41785489)
130. Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. Leyva F, Foley PWX, Stegemann B, Ward JA, Ng LL, Frenneaux MP, Regoli F, Smith REA, Auricchio A, Heart 2009 95 19 1619 1625 10.1136/hrt.2009.173880 19592389